1. Using Fludarabine to Reduce Exposure to Alkylating Agents in Children with Sickle Cell Disease Receiving Busulfan, Cyclophosphamide, and Antithymocyte Globulin Transplant Conditioning: Results of a Dose De-Escalation Trial 
John T. Horan, Ann Haight, Jacqueline Lagerlof Dioguardi, Clark Brown, Audrey Grizzle, Chiani Shelman, Julie Kanter, Greg Hale, Michael Nieder, Melody Benton, Kimberly A. Kasow, Allistair Abraham, Kuang-Yueh Chiang 
Biology of Blood and Marrow Transplantation 
Volume 21, Issue 5, Pages (May 2015)
DOI: /j.bbmt
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
(A) Changes in CD3+ peripheral blood chimerism level over time. (B) Changes in CD33+ peripheral blood chimerism level over time.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions